Increased HIF-1α expression in T cells and associated with enhanced Th17 pathway in systemic lupus erythematosus

Perl, 2017, Review: metabolic control of immune system activation in rheumatic diseases, Arthritis Rheumatol, 69, 2259, 10.1002/art.40223 Menk, 2018, Early TCR signaling induces rapid aerobic glycolysis enabling distinct acute T cell effector functions, Cell Rep, 22, 1509, 10.1016/j.celrep.2018.01.040 Shin, 2020, Mitochondrial oxidative phosphorylation regulates the fate decision between pathogenic Th17 and regulatory T cells, Cell Rep, 30, 1898, 10.1016/j.celrep.2020.01.022 Wang, 1995, Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension, Proc Natl Acad Sci USA, 92, 5510, 10.1073/pnas.92.12.5510 Semenza, 2007, Hypoxia-inducible factor 1 (HIF-1) pathway, Sci STKE, 2007, cm8, 10.1126/stke.4072007cm8 Kuschel, 2012, Functional regulation of HIF-1alpha under normoxia--is there more than post-translational regulation?, J Cell Physiol, 227, 514, 10.1002/jcp.22798 Palazon, 2014, HIF transcription factors, inflammation, and immunity, Immunity, 41, 518, 10.1016/j.immuni.2014.09.008 Larbi, 2010, Induction of HIF-1alpha and the glycolytic pathway alters apoptotic and differentiation profiles of activated human T cells, J Leukoc Biol, 87, 265, 10.1189/jlb.0509304 Cho, 2019, Hypoxia-inducible factors in CD4(+) T cells promote metabolism, switch cytokine secretion, and T cell help in humoral immunity, Proc Natl Acad Sci U S A, 116, 8975, 10.1073/pnas.1811702116 Chen, 2020, Kidney tissue hypoxia dictates T cell-mediated injury in murine lupus nephritis, Sci Transl Med, 12, 10.1126/scitranslmed.aay1620 Dang, 2011, Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1, Cell, 146, 772, 10.1016/j.cell.2011.07.033 Shi, 2011, HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells, J Exp Med, 208, 1367, 10.1084/jem.20110278 Sharabi, 2020, T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy, Nat Rev Rheumatol, 16, 100, 10.1038/s41584-019-0356-x Islam, 2021, Hypoxia-inducible factor-1 drives divergent immunomodulatory functions in the pathogenesis of autoimmune diseases, Immunology, 164, 31, 10.1111/imm.13335 Shan, 2017, IL-17-triggered downregulation of miR-497 results in high HIF-1alpha expression and consequent IL-1beta and IL-6 production by astrocytes in EAE mice, Cell Mol Immunol, 14, 909, 10.1038/cmi.2017.12 Zhao, 2018, RNAi silencing of HIF-1alpha ameliorates lupus development in MRL/lpr mice, Inflammation, 41, 1717, 10.1007/s10753-018-0815-6 Fernandez, 2009, Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation, J Immunol, 182, 2063, 10.4049/jimmunol.0803600 Clough, 2016, The gene expression omnibus database, Methods Mol Biol, 1418, 93, 10.1007/978-1-4939-3578-9_5 Hochberg, 1997, Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 40, 1725, 10.1002/art.1780400928 Gladman, 2002, Systemic lupus erythematosus disease activity index 2000, J Rheumatol, 29, 288 Del Rey, 2017, Hif-1alpha knockdown reduces glycolytic metabolism and induces cell death of human synovial fibroblasts under normoxic conditions, Sci Rep, 7, 3644, 10.1038/s41598-017-03921-4 Graumann, 2003, Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult, Brain Pathol, 13, 554, 10.1111/j.1750-3639.2003.tb00485.x Ivan, 2014, miR-210: fine-tuning the hypoxic response, Adv Exp Med Biol, 772, 205, 10.1007/978-1-4614-5915-6_10 Mimouna, 2011, Crohn disease-associated Escherichia coli promote gastrointestinal inflammatory disorders by activation of HIF-dependent responses, Gut Microb, 2, 335, 10.4161/gmic.18771 Loukovaara, 2014, Elevated protein carbonyl and HIF-1alpha levels in eyes with proliferative diabetic retinopathy, Acta Ophthalmol, 92, 323, 10.1111/aos.12186 Tsokos, 2016, New insights into the immunopathogenesis of systemic lupus erythematosus, Nat Rev Rheumatol, 12, 716, 10.1038/nrrheum.2016.186 Vukelic, 2020, T cell metabolism in lupus, Immunometabolism, 2, 10.20900/immunometab20200009 Jacobs, 2008, Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways, J Immunol, 180, 4476, 10.4049/jimmunol.180.7.4476 Garchow, 2021, HIF-1alpha and miR-210 differential and lineage-specific expression in systemic lupus erythematosus, Mol Immunol, 133, 128, 10.1016/j.molimm.2021.02.019 Kono, 2019, Glutaminase 1 inhibition reduces glycolysis and ameliorates lupus-like disease in MRL/lpr mice and experimental autoimmune encephalomyelitis, Arthritis Rheumatol, 71, 1869, 10.1002/art.41019 Wong, 2008, Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity, Clin Immunol, 127, 385, 10.1016/j.clim.2008.01.019 Moulton, 2011, Abnormalities of T cell signaling in systemic lupus erythematosus, Arthritis Res Ther, 13, 207, 10.1186/ar3251 Morel, 2017, Immunometabolism in systemic lupus erythematosus, Nat Rev Rheumatol, 13, 280, 10.1038/nrrheum.2017.43 Caielli, 2021, Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE, Cell, 184, 4464, 10.1016/j.cell.2021.07.021 Caielli, 2019, A CD4(+) T cell population expanded in lupus blood provides B cell help through interleukin-10 and succinate, Nat Med, 25, 75, 10.1038/s41591-018-0254-9 Yin, 2015, Normalization of CD4+ T cell metabolism reverses lupus, Sci Transl Med, 7, 274ra18, 10.1126/scitranslmed.aaa0835